Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Reliable Cancer Therapies (RCT) is a non-profit organization based in Switzerland that provides research-based information on cancer therapies and selectively funds the development of promising therapies.
RCT investigates information on cancer therapies for evidence to then inform the public about evidence-based cancer treatment choices. We help cancer patients and caregivers to structure and absorb the complex nature of cancer information for their decision-making on registered complementary or alternative therapies.
RCT is continuously looking for cancer therapies that have never been thoroughly examined and consider financing cancer treatments that can be deemed promising based on measurable results.
Reliable Cancer Therapies (RCT) announces € 300 000 for projects repurposing existing drugs for cancer treatment. The drugs must have been developed and approved for other indication(s). Relevant clinical trial endpoints (cancer survival & tumor response) should be the primary research assessments.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: cbarnwell@imim.es Ext.: 1670
Marta López: mlopez4@imim.es Ext.: 1576
Convocatòria (URL)
http://www.reliablecancertherapies.com/call-for-cancer-projects
Requisits
  • Medical Degree required for Principal Investigator (PI) or co-PI
  • 1 application per PI
  • Resubmission is allowed (please indicate the reason for previous decline)
    • Dotació
    $300,000
    Durada
    3 years

    Arxius

    Arxiu